ASTH - Astrana Health, Inc. (ASTH) Q2 2025 Earnings Call Transcript
2025-08-08 13:18:59 ET
Astrana Health, Inc. (ASHT)
Q2 2025 Earnings Conference Call
August 07, 2025 05:30 PM ET
Company Participants
Brandon K. Sim - President & CEO
Chandan Basho - CFO, COO & Corporate Secretary
Conference Call Participants
Andrew Mok - Barclays Bank PLC, Research Division
Craig Jones - BofA Securities, Research Division
David Michael Larsen - BTIG, LLC, Research Division
Hua Ha - Robert W. Baird & Co. Incorporated, Research Division
Jack Garner Slevin - Jefferies LLC, Research Division
Jailendra P. Singh - Truist Securities, Inc., Research Division
Matthew Dale Gillmor - KeyBanc Capital Markets Inc., Research Division
Ryan M. Langston - TD Cowen, Research Division
Presentation
Operator
Good day, everyone, and welcome to today's Astrana Health Second Quarter 2025 Earnings Call. [Operator Instructions] Today's speakers will be Brandon Sim, President and Chief Executive Officer of Astrana Health; and Chandan Basho, Chief Operating and Financial Officer. The press release announcing Astrana Health, Inc.'s results for the second quarter ended March 31, 2025, is available at the Investors section of the company's website at www.astranahealth.com. The company will discuss certain non-GAAP measures during this call. Reconciliations to the most comparable GAAP measures are included in the press release. To provide some additional background on its results, the company has made a supplemental deck available on its website. A replay of this broadcast will also be made available at Astrana Health website after the conclusion of this call.
Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed herein contain certain forward-looking statements within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terms such as anticipate, believe, expect, future, plan, outlook and will and include, among other things, statements regarding the company's guidance for the year ending December 31, 2025, continued growth, acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, liquidity, operational focus, strategic growth plans and acquisition integration efforts....
Astrana Health, Inc. (ASTH) Q2 2025 Earnings Call Transcript